Sanegene Bio
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
Domain
sanegenebio.com
Country
United StatesIndustry
BiopharmaEmployees
51-100
Last Funding
$110.0M
Founded
2020
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Sanegene Bio use?+
We have not yet detected technologies for Sanegene Bio.
What industry is Sanegene Bio in?+
Sanegene Bio operates in the Biopharma industry.
Where is Sanegene Bio based?+
Sanegene Bio is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026